Frequently Asked Questions
The market is segmented based on , By Type (Prefilled Syring Package, and Vial Package), Application (Wet Macular Degeneration, Metastatic Colorectal Cancer, Diabetic Macular Oedema, Diabetic Retinopathy, Others), Route of Administration (Intravenous and Intravitreal Injection), End-Users (Clinics, Hospitals, Diagnostic centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Aflibercept Market size was valued at USD 8343.15 USD Million in 2021.
The Global Aflibercept Market is projected to grow at a CAGR of 5.4% during the forecast period of 2022 to 2029.
The major players operating in the market include Bayer, Sanofi, Santen Pharmaceutical, Regeneron Pharmaceuticals, F. HoffmannLa Roche, Amgen, Pfizer, Xbrane Biopharma, Allergan, Viatris..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..